QL
GPCR icon

Quarry LP’s Structure Therapeutics GPCR Stock Holding History

Quarry LP’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1K Buy
+245
New +$10.8K ﹤0.01% 903
2024
Q3 		– Sell
-2,000
Closed -$78.5K – 1808
2024
Q2 		$78.5K Buy
+2,000
New +$82.1K 0.02% 449

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quarry LP's GPCR Position: Q2 2026 in Review

Quarry LP opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 245 shares worth $13.1K. The stake represents ﹤0.01% of the portfolio and ranks #903 among its holdings. This is a return to the name: Quarry LP previously reported a position in GPCR as recently as Q2 2024.

Quarry LP first reported a position in GPCR in Q2 2024 and has held it in 2 quarters since. The position peaked at $78.5K in Q2 2024. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Quarry LP held 245 shares of Structure Therapeutics worth $13.1K as of Q2 2026.
  • Structure Therapeutics was a new Quarry LP position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #903 holding.
  • Quarry LP first reported a position in Structure Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • Quarry LP's Structure Therapeutics position peaked at $78.5K in Q2 2024.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.